GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
Items 201–300 of 561
The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats
Laconi, M. R., Casteller, G., Gargiulo, P. A., Bregonzio, C., & Cabrera, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00865-2 · Cited by 72
Pinna, G., & Rasmusson, A. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02234.x · Cited by 74
Luchetti, S., Bossers, K., Frajese, G. V., & Swaab, D. F. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00396.x · Cited by 76
Neuroimaging Evidence of Cerebellar Involvement in Premenstrual Dysphoric Disorder
Rapkin, A. J., Berman, S. M., Mandelkern, M. A., Silverman, D. H. S., Morgan, M., & London, E. D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.029 · Cited by 72
Bailey, S. J., Ravier, M. A., & Rutter, G. A. (2007) · Diabetes · doi:10.2337/db06-0712 · Cited by 72
Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA
Hantsoo, L. V., & Payne, J. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105168 · Cited by 94
Pinna, G. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833d8ba0 · Cited by 71
“…S-norfluoxetine, may be devoid of the unwanted side-effects that may be caused by a ‘neurosteroid replacement therapy’ with direct systemic administration of allopregnanolone and congeners (Phillipps, 1975; Gee et al., 1988; Smith et al., 1998; Reddy and Rogawski, 2000; Reddy and Woodward, 2004).”
BackgroundNiibori, Y., Lee, S. J., Minassian, B. A., & Hampson, D. R. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.225 · Cited by 71
Mtchedlishvili, Z., Bertram, E. H., & Kapur, J. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00453.x · Cited by 71
“Allosteric modulation of GABA receptor function by allopregnanolone is markedly decreased when the a4 (Smith et al. 1998a) or d subunits are expressed (Zhu et al. 1996).”
BackgroundBiopsychosocial aspects of premenstrual syndrome and premenstrual dysphoric disorder
Matsumoto, T., Asakura, H., & Hayashi, T. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705383 · Cited by 99
Progesterone for premenstrual syndrome
Ford, O., Lethaby, A. E., Roberts, H., & Mol, B. W. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003415.pub4 · Cited by 69
Fiore, C., Inman, D. M., Hirose, S., Noble, L. J., Igarashi, T., & Compagnone, N. A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.10821 · Cited by 69
“Moreover, neurosteroid interaction at the GABAA receptor have been shown to be dependent on the specific subunit composition of the GABAA receptor (Smith et al., 1998a,b).”
BackgroundLack of Anticonvulsant Tolerance to the Neuroactive Steroid Pregnanolone in Mice
Kokate, T. G., Yamaguchi, S.-I., Pannell, L. K., Rajamani, U., Carroll, D. M., Grossman, A. B., & Rogawski, M. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37827-9 · Cited by 68
“Recently, Smith et al. (1998) reported that withdrawal from physiological levels of progesterone (a precursor for pregnanolone) was associated with increased susceptibility to benzodiazepine receptor inverse agonist-induced seizures (attributed to enhanced desensitization of GABAA receptors) and…”
Haage, D., & Johansson, S. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.1.143 · Cited by 69
“…of allopregnanolone among the studies reported, sincea-, g-, ande-subunits have all been reported to influence the effect of allopregnanolone (Belelli et al. 1996; Brussaard et al. 1997; Davies et al. 1997; Hauser et al. 1996; Lan et al. 1991; Shingai et al. 1991; see also Smith et al. 1998).”
BackgroundAnti‐apoptotic effects of allopregnanolone on P19 neurons
Xilouri, M., & Papazafiri, P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04548.x · Cited by 78
“It seems therefore that neurosteroids could affect gene expression, probably through the generation of metabolites that are ligands for steroid receptors (Rupprecht et al., 1993; Weiland & Orchinik, 1995; Steiger & Russek, 2004).”
BackgroundHormonal Effects on Epilepsy in Women
Klein, P., & Herzog, A. G. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb02602.x · Cited by 70
Moran, M. H., Goldberg, M., & Smith, S. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00781-1 · Cited by 66
Self-citationPletzer, B. A., Winkler-Crepaz, K., & Hillerer, K. M. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101060 · Cited by 77
“…al., 1991; Wilson, 1992; Finn and Gee, 1993; Martin and Williams, 1995; McCauley and Gee, 1995; Brann et al., 2002; Lovick, 2008), during pregnancy (Concas et al., 1999) or using a progesterone withdrawal paradigm (Costa et al., 1995; Smith et al., 1998; Hsu and Smith, 2003; Smith and Gong, 2005).”
BackgroundMethodResponse to Flumazenil in Women With Premenstrual Dysphoric Disorder
Le Mellédo, J.-M., Van Driel, M., Coupland, N. J., Lott, P., & Jhangri, G. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.821 · Cited by 64
“It is interesting to note that our results contradict those of the proposed progesterone-withdrawal animal model for premenstrual syndrome (8).”
ResultLovick, T. A. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2005.032342 · Cited by 63
He, X., Węgiel, J., & Yang, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.022 · Cited by 67
Carver, C. M., Wu, X. Y., Gangisetty, O., & Reddy, D. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0596-14.2014 · Cited by 65
“…of catamenial epilepsy is poorly understood, there is growing evidence suggesting that perimenstrual neurosteroid withdrawal (NSW) may be a key triggering factor for catamenial seizures (Smith et al., 1998a,b; Reddy et al., 2001, 2012; Reddy, 2009; Gangisetty and Reddy, 2010; Pack et al., 2011).”
BackgroundMethodPleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease
Boero, G., Porcu, P., & Morrow, A. L. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100203 · Cited by 65
“Other animal studies have suggested that progesterone withdrawal and therefore by analogy, withdrawal from allopregnanolone can lead to anxiety, GABAA receptor dysregulation and dysfunction (Costa et al., 1995; Moran et al., 1998; Moran and Smith, 1998; Smith et al., 1998).”
Serra, M., Mostallino, M. C., Talani, G., Pisu, M. G., Carta, M., Mura, M. L., Floris, I., Maciocco, E., Sanna, E., & Biggio, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03850.x · Cited by 63
“Withdrawal of progesterone or EtOH thus resulted in increased expression of the a4 subunit as well as a decreased seizure threshold and increased anxiogenic behaviour in rats (Mahmoudi et al. 1997; Smith et al. 1998; Reddy and Rogawski 2000; Gulinello et al. 2001).”
BackgroundRapkin, A. J., Mikacich, J. A., Moatakef-Imani, B., & Rasgon, N. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0069-7 · Cited by 71
“Rodent studies of exposure to and withdrawal from allopregnanolone reveal decreased sensitivity of GABAA receptors to GABA agonists, resulting in insensitivity to endogenous anxiolytic neurosteroids or to benzodiazepines [12].”
BackgroundNeurosteroids and their role in sex-specific epilepsies
Reddy, D. S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.010 · Cited by 71
Effect of the α subunit subtype on the macroscopic kinetic properties of recombinant GABAA receptors
Picton, A. J., & Fisher, J. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.050 · Cited by 61
“The increase in seizure activity could be reduced by decreasing α4 subunit expression (Smith et al., 1998) or by increasing α1 subunit expression (Raol et al.”
BackgroundMethodResultInfluentialMenstrual cycle interval and ovulation in women with localization-related epilepsy
Herzog, A. G., & Friedman, M. (2001) · Neurology · doi:10.1212/wnl.57.11.2133 · Cited by 61
Molecular pathways controlling inhibitory receptor expression
Grabenstatter, H. L., Russek, S. J., & Brooks‐Kayal, A. R. (2012) · Epilepsia · doi:10.1111/epi.12036 · Cited by 68
“9):71–78, 2012 doi: 10.1111/epi.12036 (Kokate et al., 1996; Smith et al., 1998, 2007), resulting in enhanced neuronal excitability, seizure susceptibility, and benzodiazepine resistance.”
BackgroundInfluentialNeurosteroid regulation of GABAA receptors: A role in catamenial epilepsy
Joshi, S., & Kapur, J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.031 · Cited by 66
Saalmann, Y. B., Kirkcaldie, M. T. K., Waldron, S., & Calford, M. B. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01527.x · Cited by 60
Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome
Lombardi, I., Luisi, S., Quirici, B., Monteleone, P., Bernardi, F., Liut, M., Casarosa, E., Palumbo, M., Petraglia, F., & Genazzani, A. R. (2004) · Gynecological Endocrinology · doi:10.1080/09513590310001652955 · Cited by 60
Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor
Strömberg, J., Haage, D., Taube, M., Bäckström, T. C., & Lundgren, P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.031 · Cited by 59
Kask, K., Gulinello, M. E., Bäckström, T. C., Geyer, M. A., & Poromaa, I. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301599 · Cited by 64
“…also indicate that it is administration of progesterone (or its neuroactive metabolite, allopregnanolone) that is associated with anxiety-like behaviors (Gallo and Smith, 1993; Moran and Smith, 1998; Smith et al, 1998a, b) including increased ASR (Gulinello et al, 2003; Gulinello and Smith, 2003).”
Increased neurosteroids synthesis after brain and spinal cord injury in rats
di Michele, F., Lekieffre, D., Pasini, A., Bernardi, G., Bénavidès, J., & Romeo, E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00965-4 · Cited by 60
Hsu, F.-C., & Smith, S. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00195.2002 · Cited by 58
Self-citationOkuno, T., Ago, H., Terawaki, K., Miyano, M., Shimizu, T., & Yokomizo, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307335200 · Cited by 56
Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders
Wihlbäck, A., Poromaa, I. S., & Bäckström, T. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0185-2 · Cited by 59
“This has occurred concomitant with an increase in the α4 subunit of the GABAA receptor in the hippocampus (Gallo and Smith 1993; Smith et al. 1998b,c).”
BackgroundFollesa, P., Cagetti, E., Mancuso, L., Biggio, F., Manca, A., Maciocco, E., Massa, F., Desole, M. S., Carta, M., Busonero, F., et al. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00164-4 · Cited by 58
Ethanol and neurosteroid interactions in the brain
Morrow, A. L., VanDoren, M. J., Fleming, R. L., & Penland, S. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46068-5 · Cited by 60
Matsui, D., Sakari, M., Sato, T., Murayama, A., Takada, I., Kim, M.-S., Takeyama, K.-I., & Kato, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1387 · Cited by 58
Recent advances in GABA research
Kardos, J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00036-4 · Cited by 57
Progesterone modulates neuronal excitability bidirectionally
Kapur, J., & Joshi, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135619 · Cited by 60
“The subunit expression is again upregulated after discontinuation of progesterone or THP treatment [142, 143].”
BackgroundDiagnosis and management of catamenial seizures: a review
Verrotti, A., D'Egidio, Agostinelli, Verrotti., & Pavone, P. (2012) · International Journal of Women s Health · doi:10.2147/ijwh.s28872 · Cited by 58
Gangisetty, O., & Reddy, D. S. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.04.016 · Cited by 53
“These results are consistent with the previous studies demonstrating that progesterone or neurosteroid withdrawal increases the α4 subunit expression in the hippocampus (Smith et al., 1998;Gulinello et al. 2001).”
BackgroundResultInfluentialSocial isolation‐induced increase in the sensitivity of rats to the steroidogenic effect of ethanol
Serra, M., Pisu, M. G., Floris, I., Cara, V., Purdy, R. H., & Biggio, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01680.x · Cited by 53
Stoffel‐Wagner, B., Watzka, M., Steckelbroeck, S., Ludwig, M. Z., Clusmann, H., BIDLINGMAIER, F., Casarosa, E., Luisi, S. V., Elger, C. E., & Beyenburg, S. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00036-6 · Cited by 58
Neurosteroid Effects on GABAergic Synaptic Plasticity in Hippocampus
Hsu, F., Waldeck, R. F., Faber, D. S., & Smith, S. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00780.2002 · Cited by 55
“As described previously (Smith et al. 1998a), 18 base pair antisense oligonucleotides were constructed +5 to the codon initiating translation for the α4 GABAR subunit (Genosys/Sigma), phosphorothioated at all positions and purified with high pressure liquid chromatography.”
BackgroundMethodSelf-citationThe Influence of Subchronic Administration of the Neurosteroid Allopregnanolone on Sleep in the Rat
Damianisch, K., Rupprecht, R., & Lancel, M. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00242-1 · Cited by 53
“…with previous studies in rats showing that allopregnanolone withdrawal - produced by withdrawal from chronic exposure to progesterone- increases neuronal excitability, which is due to a decrease in GABAergic inhibition (Smith et al. 1998) and reflected by increased anxiety (Gallo and Smith 1993).”
BackgroundResultDunn, S. M. J., Davies, M., Muntoni, A. L., & Lambert, J. J. (1999) · PubMed · Cited by 53
Ferando, I., & Mody, I. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00144 · Cited by 52
“Thus far, δ-GABAARs plasticity has been reported only in neurons expressing α4-GABAAR (Smith et al., 1998; Sundström Poromaa et al., 2002; Maguire et al., 2005, 2009) that is considered natural partner of δ-GABAAR (McKernan and Whiting, 1996; Sur et al., 1999) in the forebrain.”
BackgroundGene expression profiling in the human alcoholic brain
Warden, A. S., & Mayfield, R. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.017 · Cited by 59
“GABAergic signaling has also been implicated in increasing withdrawal-induced anxiety (Leung et al., 2015; Smith et al., 1998).”
Bohnsack, J. P., Hughes, B. A., O’Buckley, T. K., Edokpolor, K. S., Besheer, J., & Morrow, A. L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0034-8 · Cited by 55
“Decreases in α1 expression and increases in α4 expression are thought to mediate changes in benzodiazepine sensitivity, seizure susceptibility, and increased anxiety-like behavior [9, 14, 50, 51].”
Modulation of GABAA receptor gene expression by allopregnanolone and ethanol
Follesa, P., Biggio, F., Caria, S., Gorini, G., & Biggio, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.041 · Cited by 56
A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies
Morrow, A. L., Boero, G., & Porcu, P. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14253 · Cited by 56
“Other animal studies have suggested that progesterone withdrawal and therefore by analogy, withdrawal from allopregnanolone can lead to anxiety, GABAA receptor dysregulation and dysfunction (Costa et al., 1995, Smith et al., 1998, Moran and Smith, 1998, Moran et al., 1998).”
BackgroundPathophysiological power of improper tonic GABAA conductances in mature and immature models
Egawa, K., & Fukuda, A. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00170 · Cited by 62
“In a rat model of premenstrual dystrophic disorders, withdrawal of progesterone leads to anxiety and increased seizure susceptibility, associated with up-regulation of the α4 subunit (Smith et al., 1998).”
BackgroundBrack, K. E., & Lovick, T. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.058 · Cited by 51
Isles, A. R., Davies, W., Burrmann, D., Burgoyne, P. S., & Wilkinson, L. S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh203 · Cited by 51
Conditional Regulation of Neurosteroid Sensitivity of GABAA Receptors
Brussaard, A. B., & Koksma, J.-J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1286.003 · Cited by 51
Fidecicchi, T., Giannini, A., Chedraui, P. A., Luisi, S. V., Battipaglia, C., Genazzani, A. R., Genazzani, A. D., & Simoncini, T. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108087 · Cited by 70
Smith, S. S., & Gong, Q. H. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077297 · Cited by 54
“Results from the present study demonstrate that recombinant α4β2δ and α4β2γ 2 GABARs deactivate with an accelerated τ fast, compared to α1β2γ 2 and α5β2γ 2, which are normally highly expressed in CA1 hippocampal pyramidal cells (Wisden et al. 1992; Nusser et al. 1996; Crestani et al. 2002; Liang et al. 2004).”
BackgroundMethodSelf-citationA Mouse Kindling Model of Perimenstrual Catamenial Epilepsy
Reddy, D. S., Gould, J., & Gangisetty, O. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192377 · Cited by 55
“Similar increases in α 4-subunit and its pharmacological properties have been described after withdrawal from P or neurosteroids (Smith et al., 1998ab).”
BackgroundMethodResultInfluentialGao, M., Gao, D., Sun, H. J., Cheng, X., An, L., & Qiao, M. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.596128 · Cited by 90
Herbison, A. E. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)33003-0 · Cited by 50
Genetic manipulations of GABAA receptor in mice make inhibition exciting
Vicini, S., & Ortinski, P. I. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.001 · Cited by 58
Distribution of seizures across the menstrual cycle in women with epilepsy
Herzog, A. G., Fowler, K. M., Sperling, M. R., Massaro, J. M., & Progesterone Trial Study Group (2015) · Epilepsia · doi:10.1111/epi.12969 · Cited by 48
Allopregnanolone levels and seizure frequency in progesterone-treated women with epilepsy
Herzog, A. G., & Frye, C. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000623 · Cited by 49
Impact of the Hormonal Milieu on the Neurobiology of Alcohol Dependence and Withdrawal
Devaud, L. L., Risinger, F. O., & Selvage, D. J. (2006) · The Journal of General Psychology · doi:10.3200/genp.133.4.337-356 · Cited by 56
Steroid Modulation of GABAA Receptors
Lambert, J. J., Peters, J. A., Harney, S. C., & Belelli, D. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6_4 · Cited by 49
Cellular Mechanism of Pulsatile LHRH Release1
Terasawa, E. (1998) · General and Comparative Endocrinology · doi:10.1006/gcen.1998.7155 · Cited by 56
Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy
Reddy, D. S. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00101 · Cited by 49
“A sudden cessation of progesterone after chronic administration for 3 weeks leads to proconvulsant effects (Smith et al., 1998a,b).”
BackgroundMethodResultInfluentialGlial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy
Sharma, S., Puttachary, S., & Thippeswamy, T. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24205 · Cited by 52
“…has anticonvulsant, anxiolytic, and neuroprotective properties (Reddy, 2003, 2004, 2009, 2010; Scharfman & MacLusky, 2006), and therefore it plays a significant role in epilepsy, anxiety, and depression (Reddy, 2003; Reddy & Jian, 2010; Smith et al., 1998; Van Broekhoven and Verkes, 2003).”
BackgroundGrobin, A. C., Gizerian, S. S., Lieberman, J. A., & Morrow, A. L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.026 · Cited by 52
Kaltsouni, E., Fisher, P. M., Dubol, M., Hustad, S., Lanzenberger, R. R., Frøkjær, V. G., Wikström, J., Comasco, E., & Poromaa, I. S. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01010-9 · Cited by 48
Reddy, D. S. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13028 · Cited by 47
Werner, D. F., Kumar, S., Criswell, H. E., Suryanarayanan, A., Fetzer, J. A., Comerford, C. E., & Morrow, A. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07140.x · Cited by 46
“Although work has shown that knockdown of GABAA receptor a4 subunit prevents progesterone withdrawal properties (Smith et al. 1998a,b), that are similar to ethanol withdrawal properties, no studies have definitively linked GABAA receptor a4 subunits to altered behavioral responses from ethanol…”
BackgroundPuberty, steroids and GABAA receptor plasticity
Smith, S. S., Aoki, C. J., & Shen, H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.011 · Cited by 52
Self-citationFollesa, P., Mancuso, L., Biggio, F., Mostallino, M. C., Manca, A., Mascia, M. P., Busonero, F., Talani, G., Sanna, E., & Biggio, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.896 · Cited by 48
Neuroendocrinological aspects of epilepsy: Important issues and trends in future research
Pack, A. M., Reddy, D. S., Duncan, S., & Herzog, A. G. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.02.009 · Cited by 49
Lovick, T. A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.12.014 · Cited by 48
Translational approach to studying panic disorder in rats: Hits and misses
Schenberg, L. C., Schimitel, F. G., Armini, R. D. S., Bernabe, C., Rosa, C. A., Tufik, S., Müller, C. J. T., & Quintino-dos-Santos, J. W. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.002 · Cited by 47
Aromatase inhibitors as add–on treatment for men with epilepsy
Harden, C. L., & MacLusky, N. J. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.123 · Cited by 43
Neurosteroids: Endogenous Modulators of Seizure Susceptibility
Rogawski, M. A., & Reddy, D. S. (2004) · Cited by 49
GABAA-receptor plasticity during long-term exposure to and withdrawal from progesterone
Biggio, G., Follesa, P., Sanna, E., Purdy, R. H., & Concas, A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46064-8 · Cited by 47
Premenstrual syndrome and premenstrual dysphoric disorder in adolescents
Rapkin, A. J., & Mikacich, J. A. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283094b79 · Cited by 52
Progesterone withdrawal increases the anxiolytic actions of gaboxadol: role of α4βδ GABAA receptors
Gulinello, M. E., Gong, Q., & Smith, S. S. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00008 · Cited by 43
Self-citationMolecular Pathways of Anxiety Revealed by Knockout Mice
Tóth, M., & Wood, S. J. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:2-3:101 · Cited by 45
Neurosteroid modulation of recombinant and synaptic GABAA receptors
Lambert, J. J., Harney, S. C., Belelli, D., & Peters, J. A. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46063-6 · Cited by 46
NEWHOUSE, P. A., Dumas, J. A., Hancur-Bucci, C., Naylor, M. R., Sites, C. K., Benkelfat, C., & Young, S. N. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301530 · Cited by 45
Regulation of Uterine γ-Aminobutyric AcidAReceptor Subunit Expression throughout Pregnancy1
Fujii, E., & Mellon, S. H. (2001) · Endocrinology · doi:10.1210/endo.142.5.8153 · Cited by 41
Allopregnanolone modulation of HPA axis function in the adult rat
Biggio, G., Pisu, M. G., Biggio, F., & Serra, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3521-6 · Cited by 40
“Moreover, withdrawal of progesterone or ethanol in rats also resulted in increased expression of the α4 subunit in the brain as well as in a reduced seizure threshold and increased anxiogenic behavior (Mahmoudi et al. 1997; Smith et al. 1998; Reddy and Rogawski 2000; Gulinello et al. 2001).”
BackgroundVariation of Seizure Frequency with Ovulatory Status of Menstrual Cycles
Herzog, A. G., Fowler, K. M., Sperling, M. R., Liporace, J., Kalayjian, L., Heck, C., Krauss, G., Dworetzky, B. A., & Pennell, P. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03194.x · Cited by 39
“Further, progesterone can regulate the subtype composition of the GABAA receptor to modulate its sensitivity to synaptic GABA and pharmacologic input (Hsu & Smith 2003; Smith et al. 1998; Maguire et al. 2005).”
BackgroundHormonal Therapies: Progesterone
Herzog, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.01.009 · Cited by 40
“nor Haider and Barnett(68) reported exacerbation of seizures with GnRH analogs, we have found that during the first 3 weeks, when there is an initial stimulation of ovarian estradiol production before it is inhibited, women may experience a marked exacerbation of their seizures.(36,71)”
BackgroundPremenstrual enhancement of snake detection in visual search in healthy women
Masataka, N., & Shibasaki, M. (2012) · Scientific Reports · doi:10.1038/srep00307 · Cited by 45
“Research with animals demonstrated increased anxiety upon administration of progesterone, suggesting that progesterone affects parts of the brain related to anxiety and moo”
BackgroundMolecular mechanisms of tolerance to and withdrawal of GABAA receptor modulators
Biggio, G., Dazzi, L., Biggio, F., Mancuso, L., Talani, G., Busonero, F., Mostallino, M. C., Sanna, E., & Follesa, P. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.002 · Cited by 42
Mass spectrometric assay and physiological–pharmacological activity of androgenic neurosteroids
Reddy, D. S. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.05.019 · Cited by 40
“…role in the pathophysiology of brain disorders such as generalized anxiety disorder, depression, epilepsy and stress (Herzog, 1995; Reddy et al., 2001; Smith et al., 1998; Monteleone et al., 2000; Purdy et al., 1991; Reddy and Rogawski, 2002; Dong et al., 2001; Reddy 2003a; 2004a; 2005; 2006).”
BackgroundSabaliauskas, N., Shen, H., Molla, J., Gong, Q. H., Kuver, A., Aoki, C., & Smith, S. S. (2015) · Brain Research · doi:10.1016/j.brainres.2014.12.026 · Cited by 39
Self-citationNoriega, N. C., Eghlidi, D. H., Garyfallou, V. T., Kohama, S. G., Kryger, S. G., & Urbanski, H. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.10.011 · Cited by 46
“Note also that P or THP withdrawal increases α4 subunit expression in the rat HPC (Smith et al., 1998a) and AMD (Gulinello et al., 2003), highlighting the possibility that steroid removal through ovariectomy may elevate expression of some GABA receptor subunits, although short-term steroid exposure…”
BackgroundIncreased neurosteroid sensitivity of hippocampal gabaa receptors during postnatal development
Mtchedlishvili, Z., Sun, C., Harrison, M. B., & Kapur, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00043-5 · Cited by 39
“…Previous studies on GABAA receptors demonstrated that allosteric modulation of GABA function by allopregnanolone is markedly increased in the presence of α1 subunit (Shingai et al., 1991; Brussaard et al., 1997) and decreased when α4 subunit expression is increased (Smith et al., 1998).”
BackgroundReddy, D. S., Mbilinyi, R. H., & Estes, E. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06427-2 · Cited by 46
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.